Form 4 for GMED GLOBUS MEDICAL INC
Accepted 2021-07-20 00:00:00 ET · period of report 2021-07-19 · accession 0001209191-21-047369 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-20 | 2021-07-19 | GMED | Pfeil Keith W | SVP, CFO | M - OptEx | $49.65 | +834 | 834 | New | +$41.4K |
| D | 2021-07-20 | 2021-07-19 | GMED | Pfeil Keith W | SVP, CFO | S - Sale+OE | $78.25 | -834 | 0 | -100% | -$65.3K |
| D | 2021-07-20 | 2021-07-19 | GMED | Pfeil Keith W | SVP, CFO | M - OptEx | $0.00 | -834 | 20.8K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-07-19 | M | A | 834 | $49.65 | 834 | D | — | — | |
| 2 | Common | Class A Common Stock | 2021-07-19 | S | D | 834 | $78.25 | 0 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2021-07-19 | M | D | 834 | $0.00 | 20,833 | D | $49.65 · — to 2029-09-03 | 834 Class A Common Stock | (F2) These options were granted on September 3, 2019, and vest over a four-year period with one-fourth (1/4) of the options vesting on August 19, 2020 and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |